Zheng Pengfei, general manager of Shunmei, said the interests of the American consumers will be inevitably damaged if the price of his products rise.

Guo Yunpei, chairman of Chinese Pharmaceutical Enterprises Association, said the proposed tariffs on pharmaceuticals will not affect the Chinese industry since it enjoys a huge domestic market.

"Some Chinese medicines are quite popular in the American market, and American buyers will have to pay more if the prices rise," he added.

Steven Carpenter, president of AmCham China's Central China Chapter, said he is disappointed in Trump and the U.S. government.

"I believe President Trump should follow the rules of the WTO and, if he believes that China is practicing unfair trade with the U.S. then let the WTO review the charges," he said.

"China has already agreed to follow WTO judgments. President Trump and the U.S. Government should follow China's lead and agree to accept the authority of the WTO judgments as well."

Trump's actions will not help generate any goodwill for American companies trying to do business in China, he added.

【国内英语资讯:China Focus: U.S. protectionism to hurt interests of its own】相关文章：

★ 石原慎太郎将辞去东京都知事一职

★ 希腊纾困调整进入倒计时

★ 英国各银行资本金缺口可能高达500亿英镑

★ 康涅狄格州发生校园枪击案

★ FT社评：希腊经济忧中带喜

★ 苹果新产品提振富士康业绩

★ 双语阅读：为时尚 为环保：请你穿上秋裤（双语）

★ 商学院寻求扩大政治视野

★ 一个公关人的商旅心得

★ 让2013成为危机转折点